Abstract:Cellular senescence is a fundamental response against chemotherapy to avoid cell death, and the resulting therapy-induced senescent (TIS) cells have been associated with cancer recurrence and therapy resistance via its paracrine activity. The paracrine activity of TIS cells is heavily influenced by the composition and dynamics of the senescence associated secretory phenotype (SASP). The SASP itself is known to be predominantly composed by soluble cytokines, chemokines, and growth factors. The non-soluble fraction of SASP, specifically small extracellular vesicles (sEVs), represents an underappreciated component of SASP and are still poorly characterized. Here we show that the SASP may mediate tumor recurrence and distant metastasis in mice, as well as support invasive and migratory behavior . Remarkably, while the SASP itself may be pro-tumorigenic, we found that therapy-induced senescent sEVs isolated from the SASP are able to reduce syngeneic tumor growth . Transcriptomic analysis from therapy-induced sEV recipient mice tissue revealed downregulation of proliferation and mitotic pathways, akin to a senescence-like phenotype, along with upregulation of inflammatory and antigen-presentation pathways. Further characterization revealed that TIS sEVs recipient cells are less invasive and migratory, and that they also exhibit elevated level of reactive oxygen species (ROS), concomitantly with sustained γ-H2AX expression and micronuclei generation. Our results indicate that therapy-induced senescent cancer cell-derived sEVs should be considered as distinct SASP entities.

What problem does this paper attempt to address?

This paper aims to explore the role of small extracellular vesicles (sEVs) in tumor development during the process of chemotherapy - induced tumor cell senescence. Specifically, the researchers focused on whether the small extracellular vesicles secreted by senescent cells caused by Paclitaxel treatment in Triple - Negative Breast Cancer (TNBC) have anti - cancer properties, and how these vesicles affect the tumor microenvironment and tumor growth. The paper mainly addresses the following issues: 1. **The impact of chemotherapy - induced senescence - associated secretory phenotype (SASP) on tumors**: The study found that after chemotherapy, tumor cells enter a senescent state, and the SASP they secrete can promote tumor growth and invasiveness. This indicates that SASP plays an important role in tumor recurrence and distant metastasis after chemotherapy. 2. **The role of small extracellular vesicles (sEVs)**: Although SASP may have a pro - tumor effect as a whole, the study found that the small extracellular vesicles isolated from chemotherapy - induced senescent cells (TIS sEVs) can reduce the growth of syngeneic tumors in vivo. These vesicles inhibit the proliferation, migration, and invasion abilities of tumor cells by down - regulating the proliferation and mitotic pathways and simultaneously up - regulating the inflammatory and antigen - presentation pathways. 3. **The mechanism of TIS sEVs**: Further research shows that TIS sEVs can increase the level of reactive oxygen species (ROS) in recipient cells, continuously express γ - H2AX, and generate micronuclei. These changes are related to genomic instability. In addition, TIS sEVs can also induce a senescence - like phenotype, such as reducing the expression of Lamin B1 and increasing the expression of p21. In conclusion, this paper reveals the dual role of small extracellular vesicles secreted by chemotherapy - induced senescent cells in tumor development. That is, they can not only promote tumor growth and invasion through SASP but also inhibit tumor development through specific mechanisms. This finding provides a new perspective for understanding tumor recurrence after chemotherapy and may provide a theoretical basis for the development of new anti - cancer strategies.

Extracellular vesicles within a tumourigenic therapy-induced senescent tumour secretome are able to confer anti-cancer properties